PCBP1在胃癌中的表达及其与铁死亡因子STUB1的关系

doi:10.3969/j.issn.1006-5725.2025.19.010

Abstract

Abstract:

Objective To investigate the expression characteristics of poly （rC）-binding protein 1 （PCBP1） in gastric cancer tissues and their clinical significances by bioinformatics analysis combined with experimental verification， and to identify its relationship with STIP1 homology and U-Box containing protein 1 （STUB1）. Specifically， this study aims to verify the expression patterns of PCBP1 and STUB1 in gastric cancer and determine their relationships with clinicopathological features by immunohistochemistry to provide a theoretical framework as well as potential intervention strategies for gastric cancer. Methods Data of PCBP1 expression in gastric cancer and adjacent tissues were obtained from TIMER 2.0 online analysis website. KEGG pathway enrichment analysis was performed using gastric cancer data （STAD） in the TCGA （the Cancer Genome Atlas） database， and its potential mechanism was determined. The main regulatory factor STUB1 was found in the ferroptosis regulatory pathway. Subsequently， PCBP1 and STUB1 expressions in 33 cases of gastric cancer tissues and corresponding adjacent tissues were detected by immunohistochemistry. The collected cases were grouped according to different degrees of differentiation， age， gender， tumor size， depth of tumor invasion， TNM stage and pathological morphology. The positive expression rates of PCBP1 and STUB1 were observed. The correlation between the two proteins and the correlation between clinical and pathological features were analyzed by c2 test. Finally， the relationship between PCBP1 and STUB1 and malignancy of gastric cancer was further explored. Results Immunohistochemical results showed that the positive expression rate of PCBP1 in cancer tissues was 69.7 %， which was significantly higher than that in adjacent tissues （48.5%）. The positive expression rate of STUB1 in cancer tissues was 39.4 %， which was lower than that in adjacent tissues （54.5 %）， statistically significant difference （P < 0.05）. The positive expression rate of PCBP1 was correlated with tumor differentiation， lymph node metastasis and Lauren classification （P < 0.05）， but not with patient's age， gender， depth of invasion， clinical stage， nerve infiltration， and intravascular tumor thrombus （P > 0.05）. The positive expression rate of STUB1 was correlated with tumor differentiation， depth of invasion， lymph node metastasis and Lauren classification （P < 0.05）. The Spearman correlation coefficient between PCBP1 （cancer） and STUB1 （cancer） was -0.413， with P = 0.017 （P < 0.05）， indicating that there was a significant negative correlation between them. Conclusion PCBP1 participates in the malignant progression of gastric cancer by regulating the main regulator STUB1 in the ferroptosis pathway. Theoretically， it provides a new insight into molecular mechanism as well as a potential therapeutic strategy for treating gastric cancer.

Key words: gastric cancer, PCBP1, STUB1, bioinformatics, iron death, immunohistochemistry

CLC Number:

R735.2

Xuman LU,Zhengyi SHI,Yuanrui LEI,Haibin HUANG,Renmiao DENG,Xudong DONG,Yuliang HUANG,Fanbiao KONG,Xiaotong. WANG. The expression of PCBP1 in gastric cancer and its relationship with ferroptosis factor STUB1[J]. The Journal of Practical Medicine, 2025, 41(19): 3026-3033.

Figures/Tables 7

Fig.1

Fig.2

Tab.1

Fig.3

Tab.2

Fig.4

Fig.5

References 28

[1]	BRAY F， LAVERSANNE M， SUNG H， et al. Global Cancer Statistics 2022： GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries［J］. CA Cancer J Clin，2024，74（3）：229-263. doi:10.3322/caac.21834 doi: 10.3322/caac.21834
[2]	丁平安，杨沛刚，田园，等. 胃癌伴左锁骨上淋巴结转移患者的临床病理特征及预后［J］. 实用医学杂志， 2021， 37 （13）： 1695-1700.
[3]	NAYAK A， KUMAR S， SINGH S P， et al. Oncogenic potential of ATAD2 in stomach cancer and insights into theprotein-protein interactions at its AAA + ATPase domain and bromodomain［J］.J Biomol Struct Dyn，2022，40（12）：5606-5622. doi:10.1080/07391102.2021.1871959 doi: 10.1080/07391102.2021.1871959
[4]	贾冰冰，叶梦，霍丽蓉. PCBP1相关生物功能的研究进展［J］. 医学研究杂志， 2018， 47 （9）： 176-179+135.
[5]	SHI H， BENCZE K Z， STEMMLER T L，et al. A cytosolic iron chaperone that delivers iron to ferritin［J］. Science， 2008，320（5880）：1207-1210. doi:10.1126/science.1157643 doi: 10.1126/science.1157643
[6]	WANG X Q， FAN A Q， HONG L. LncRNA MIR210HG promotes the proliferation of colon cancer cells by inhibiting ferroptosis through binding to PCBP1［J］. Sci Rep，2025，15（1）：871. doi:10.1038/s41598-025-85321-7 doi: 10.1038/s41598-025-85321-7
[7]	WEI F， MENG Y， ZHU D X， et al. Mechanism and role of ferroptosis in the development of gastric cancer［J］. Clin Exp Med，2025，25（1）：182. doi:10.1007/s10238-025-01722-y doi: 10.1007/s10238-025-01722-y
[8]	ZHANG L， LUO Y L， XIANG Y， et al. Ferroptosis inhibitors： Past， present and future［J］. Front Pharmacol，2024，15：1407335. doi:10.3389/fphar.2024.1407335 doi: 10.3389/fphar.2024.1407335
[9]	CUI S， SIMMONS G J， VALE G，et al. FAF1 blocks ferroptosis by inhibiting peroxidation of polyunsaturated fatty acids［J］. Proc Natl Acad Sci USA，2022，9：e2107189119. doi:10.1073/pnas.2107189119 doi: 10.1073/pnas.2107189119
[10]	SHAO M， QI K， WANG L，et al. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma［J］. Cell Signal，2024，118：111148. doi:10.1016/j.cellsig.2024.111148 doi: 10.1016/j.cellsig.2024.111148
[11]	张银亮，骆泽谭，赵睿，等. 血根碱通过调控STUB1/GPX4诱导直肠癌细胞发生铁死亡［J］. 南方医科大学学报，2024，44（8）：1537-1544.
[12]	王衍颜，张军，毛沛，等. 肺鳞状细胞癌组织PCBP1、GPSM2表达与EMT、临床病理特征和预后的关系［J］. 现代生物医学进展，2024，24（19）：3654-3656+3666.
[13]	郑荣寿，张思维，孙可欣，等. 2016年中国恶性肿瘤流行情况分析［J］.中华肿瘤杂志，2023，45（3）：212-220. doi:10.3760/cma.j.cn112152-20220922-00647 doi: 10.3760/cma.j.cn112152-20220922-00647
[14]	覃黎明，周子寒，曹骥，等. 2011—2018年广西胃癌流行特征及疾病负担分析［J］. 中国癌症防治杂志，2024，16（02）：172-179.
[15]	范文凭，林琳，刘江美，等.基于GBD数据分析1990—2019年中国恶性肿瘤疾病负担趋势［J］.中国肿瘤，2024，33（1）：20-26.
[16]	CHOI H S， HWANG C K， SONG K Y，et al. Poly（C）-binding proteins as transcriptional regulators of gene expression［J］. Biochem Biophys Res Commun，2009，380（3）：431-436. doi:10.1016/j.bbrc.2009.01.136 doi: 10.1016/j.bbrc.2009.01.136
[17]	杨杰，李卫，刘贺，等. 应用酵母双杂交筛选人胃癌耐药细胞SIVA-1基因相互作用蛋白［J］. 现代肿瘤医学，2023，31（5）：806-811.
[18]	KONG F B， SHI Z Y， HUANG Y L，et al. SIVA-1 interaction with PCBP1 serves as a predictive biomarker for cisplatin sensitivity in gastric cancer and its inhibitory effect on tumor growth in vivo［J］. J Cancer，2024，15（13）：4301-4312. doi:10.7150/jca.92963 doi: 10.7150/jca.92963
[19]	LIU R Q， WU Y T， CHENG Y，et al.TBBPA induced hepatocyte ferroptosis by PCBP1-mediated ferritinophagy［J］. J Hazard Mater，2025，494：138515. doi:10.1016/j.jhazmat.2025.138515 doi: 10.1016/j.jhazmat.2025.138515
[20]	JAIN C， SHAH Y M. PCBP1 is essential for proper iron absorption［J］. Blood， 2023，142（19）：1585-1587. doi:10.1182/blood.2023022267 doi: 10.1182/blood.2023022267
[21]	PENG K， CHEN X， LIN A，et al. PolyC-RNA-binding protein 1 （PCBP1） enhances tropomyosin 3 （TPM3） mRNA stability to promote the progression of esophageal squamous cell carcinoma［J］. Bioengineered，2022，13（4）：8581-8592. doi:10.1080/21655979.2022.2053801 doi: 10.1080/21655979.2022.2053801
[22]	MEI W， WEI M， TANG C，et al. BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancer［J］. Cell Death Dis，2025，16（1）：337. doi:10.1038/s41419-025-07559-3 doi: 10.1038/s41419-025-07559-3
[23]	JIANG Y， ZHOU H Z， ZHANG J X，et al. LINC00926， Regulated by TCF12， Modulates the Ubiquitination of GPX4 to Regulate Ferroptosis by Interacting with STUB1 in HUVECs［J］.Mol Biotechnol，2025，doi： 10.1007/s12033-025-01441-5 . doi: 10.1007/s12033-025-01441-5
[24]	ZHANG X， ZHANG Y， LI R，et al. STUB1-mediated ubiquitination and degradation of NSUN2 promotes hepatocyte ferroptosis by decreasing m5C methylation of Gpx4 mRNA［J］. Cell Rep，2024，43（11）：114885. doi:10.1016/j.celrep.2024.114885 doi: 10.1016/j.celrep.2024.114885
[25]	TIELIWAERDI A， AINI A， AMUTI M，et al. STUB1 promotes the degradation of HSPB1 and induces ferroptosis in lung cancer cells［J］. Environ Toxicol，2024，39（8）：4156-4170. doi:10.1002/tox.24296 doi: 10.1002/tox.24296
[26]	SUN X， ZHANG Q， LIN X，et al. Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination［J］. Cell Death Dis，2023，14（12）：839. doi:10.1038/s41419-023-06300-2 doi: 10.1038/s41419-023-06300-2
[27]	ZHANG L， LI Q， XU J，et al. Cimetidine promotes STUB1-mediated degradation of tumoral FOXP3 by activating PI3K-Akt pathway in gastric cancer［J］. Ann Transl Med，2020，8（20）：1304. doi:10.21037/atm-20-6070 doi: 10.21037/atm-20-6070
[28]	DAI H， CHEN H， XU J，et al.The ubiquitin ligase CHIP modulates cellular behaviors of gastric cancer cells by regulating TRAF2［J］.Cancer Cell Int，2019，19：132. doi:10.1186/s12935-019-0832-z doi: 10.1186/s12935-019-0832-z

临床病理特征	例数	PCBP1（癌）		χ²值	P值	STUB1（癌）		χ²值	P值
临床病理特征	例数	阳性/例	阳性率/%	χ²值	P值	阳性/例	阳性率/%	χ²值	P值
年龄				0.762	0.311			0.047	0.556
≤ 60岁	16	10	62.5			6	37.5
> 60岁	17	13	76.5			7	41.2
性别				2.158	0.148			1.528	0.204
男	24	15	62.5			11	45.8
女	9	8	88.9			2	22.2
分化程度				13.295	< 0.001			10.452	0.020
低分化	19	18	94.7			3	15.8
中分化	14	5	35.7			10	71.4
浸润深度				0.120	0.512			4.891	0.031
T₁—T₂	15	10	66.7			9	60.0
T₃—T₄	18	13	72.2			4	22.2
淋巴结转移				10.705	0.002			9.909	0.030
有	23	20	87.0			5	21.7
无	10	3	30.0			8	80.0
临床分期				1.963	0.154			0.863	0.284
Ⅰ—Ⅱ期	17	10	58.8			8	47.1
Ⅲ—Ⅳ期	16	13	81.3			5	31.3
Lauren分型				9.081	0.011			15.917	< 0.001
肠型	10	4	40.0			9	90.0
混合型	7	4	57.1			2	28.6
弥漫型	16	15	93.8			2	12.5
脉管侵犯				1.148	0.256			1.015	0.267
有	11	9	81.8			3	27.3
无	22	14	63.6			10	45.5
神经浸润				4.591	0.053			0.346	0.442
有	27	21	77.8			10	37.0
无	6	2	33.3			3	50.0

组合分组	例数	失访数	复发数	死亡数
PCBP1阳性& STUB1阴性	17	1	5	0
PCBP1阳性& STUB1阳性	6	0	0	0
PCBP1阴性& STUB1阳性	7	0	0	1
PCBP1阴性& STUB1阴性	3	0	0	0
χ²值			7.863	3.158
P值			0.049	0.368

The expression of PCBP1 in gastric cancer and its relationship with ferroptosis factor STUB1

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 7

References 28

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Tong DUAN,Qi WU,Hui. LIU. Correlation between iron death⁃related gene expression level and myocardial dysfunction and prognosis in sepsis [J]. The Journal of Practical Medicine, 2025, 41(6): 846-851.
[2]	Zonglin LI,Chunlin FENG,Xin LIU,Xingming SHU,Min. SONG. CCCTC⁃binding factors promote the formation of oxaliplatin related gastric cancer drug-tolerant cells by resisting apoptosis [J]. The Journal of Practical Medicine, 2025, 41(4): 490-499.
[3]	Danping WANG,Yufeng CAI,Dehua HU,Liang. ZHANG. The role of LncRNA RMST in gastric cancer： Expression levels， diagnostic value， and prognostic implicationssion [J]. The Journal of Practical Medicine, 2025, 41(3): 409-413.
[4]	Weizun LI,Chen XING,Hengqing AN. STAT activation inhibitory protein 2 is involved in reprogramming of lipid metabolism by regulating the prostate cancer development [J]. The Journal of Practical Medicine, 2025, 41(18): 2844-2852.
[5]	Jian ZHAO,Min DAI,Ran SUN,Yajun XU. Analysis of the relationship between Hp infection and the expression of p27， CyclinD1， MMP⁃9 proteins and the related microRNAs and clinicpathological features in gastric cancer [J]. The Journal of Practical Medicine, 2025, 41(18): 2890-2897.
[6]	Zhen ZHANG,Ming CHENG,Zhaoshu JIANG,Jie YANG,Zhenliang LUO,Feng. CAO. Effects of Orexin-A/OX1R/OX2R on iron death and lipid peroxidation regulation in chronic unpredictable mild stress depressed rats [J]. The Journal of Practical Medicine, 2025, 41(16): 2507-2514.
[7]	Xifeng XU,Xia WANG,Jianliang WU,Jinlong. CHENG. Effect of immunohistochemical detection of omentin-1， SPP1 and MMR protein expression status on clinicopathological features and prognosis analysis of endometrial cancer [J]. The Journal of Practical Medicine, 2025, 41(16): 2521-2527.
[8]	Qian ZHANG,Yuntai CAO,Zhijie WANG,Boqi. ZHOU. Advances in deep learning for endoscopic image⁃based diagnosis of early gastric cancer [J]. The Journal of Practical Medicine, 2025, 41(14): 2160-2166.
[9]	Xiaomei CHEN,Anqi WANG,Jizhen YANG,Miao YU. Prognosis and immune correlation analysis of m1A/m5C/m6A/m7G regulated genes in gastric cancer [J]. The Journal of Practical Medicine, 2024, 40(9): 1230-1237.
[10]	Jianliang YAN,Zeyu XIE,Rongrong JING,Ming. CUI. Research on establishing gastric cancer lymph node metastasis prediction model based on machine learning and routine laboratory indicators [J]. The Journal of Practical Medicine, 2024, 40(6): 844-849.
[11]	Shu CHEN,Jinglei ZHANG,Kang RONG,Nan ZHANG,Weiyi SUN. Research progress of exosomes in distant metastasis and drug resistance of gastric cancer [J]. The Journal of Practical Medicine, 2024, 40(6): 870-876.
[12]	Li XU,Shanshan HU,Haiming. ZHAO. LncRNA GNAS⁃AS1 participates in the proliferation and migration of gastric cancer cells by regulating the miR⁃449a/Notch1 axis [J]. The Journal of Practical Medicine, 2024, 40(4): 483-489.
[13]	Jian ZHAO,Songjie LIU,Guanchao ZHANG,Yuhou SHEN,Fengchen LI,Bing XU. Expression of CENPF and miR⁃1⁃3p in the serum of patients with advanced gastric cancer and their correlation with prognosis [J]. The Journal of Practical Medicine, 2024, 40(3): 365-370.
[14]	Jun XU,Xiaoli WANG,Jingyi NI,Didi. ZHANG. Clinical efficacy and safety of disitamab vedotin in the treatment of advanced gastric cancer [J]. The Journal of Practical Medicine, 2024, 40(20): 2913-2917.
[15]	Chunyan NIU,Xiaoping WANG,Xiangyang ZHAO,Jiankang HUANG,Yue CHEN,Yongqiang SHI,Yongqiang SONG,Hui WANG,Xinguo WU,Yongdan BU,Jijin LI,Tao TAO,Jinhua WU,Changlin XUE,Fuyu ZHANG,Jinming YANG,Chunrong HAN,Juan YUAN,Yinling WU,Hongbing XIONG,Peng XIAO. A multicenter population investigation on precancerous lesions of gastric cancer in Lishui District， Nanjing [J]. The Journal of Practical Medicine, 2024, 40(20): 2929-2934.